Abstract:Objective To compare the clinical efficacy of spinal nerve radiofrequency (rF) and spinal cord stimulation (SCS) for the treatment of postherpetic neuralgia (PHN).Method A retrospective analysis was conducted on 106 patients with PHN treated at Meizhou People's Hospital from March 2022 to March 2024. Patients were divided into two groups based on the treatment method: Group A (64 patients) received spinal nerve RF treatment, and Group B (42 patients) received SCS treatment. Treatment outcomes were compared, including Numeric Rating Scale (NRS) scores, pain difference (PD) values, Pittsburgh Sleep Quality Index (PSQI) scores, Visual Analog Scale (VAS) scores at baseline, 1, 3, and 7 weeks, infrared thermography temperature differences, and the incidence of adverse reactions.Result There was no significant difference in the overall effective rate between Group A and Group B (P > 0.05). However, the changes in NRS scores and PD values in Group B were greater than those in Group A (P < 0.05). Group B had lower PSQI scores compared to Group A (P < 0.05). The changes in infrared thermography temperature in Group A were greater than those in Group B (P < 0.05). When comparing PSQI and VAS scores at different time points, significant differences were observed (P < 0.05). Group A had higher PSQI scores and lower VAS scores compared to Group B (P < 0.05). There were no significant differences in the incidence of complications between the two groups (P > 0.05).Conclusion Spinal cord stimulation is more effective in the short term for relieving postherpetic neuralgia and improving sleep quality compared to spinal nerve radiofrequency. SCS may be a more effective treatment option and warrants further validation in larger-scale studies.